Evidence map›Paper›PMID 31182641›Full record

ArticleMolecular and cellular biology2019

CREB Promotes Beta Cell Gene Expression by Targeting Its Coactivators to Tissue-Specific Enhancers.

Sam Van de Velde, Ezra Wiater, Melissa Tran, Yousang Hwang, Philip A Cole, Marc Montminy

Open access · bronzeAbstract read
In one paragraph

Article in Molecular and cellular biology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
5.7field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 43 citations in OpenAlex.

  1. Med14 phosphorylation shapes genomic response to GLP-1 agonists.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  2. Article
  3. Article
  4. Pharmacologic reversion of Merkel cell carcinoma via CBP/p300 inhibition.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  5. Review
  6. Epigenetic Regulation of Pancreas Development and Function.Advances in anatomy, embryology, and cell biology · 2024
    Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. PGEProceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Review
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Sam Van de VeldePeptide Biology Laboratories, The Salk Institute for Biological Studies, La Jolla, California, USA.
Ezra WiaterPeptide Biology Laboratories, The Salk Institute for Biological Studies, La Jolla, California, USA.
Melissa TranPeptide Biology Laboratories, The Salk Institute for Biological Studies, La Jolla, California, USA.
Yousang HwangDepartment of Pharmacology, Johns Hopkins School of Medicine, Baltimore, Maryland, USA.
Philip A ColeDepartment of Medicine, Department of Biology, Chemistry & Molecular Pharmacology, Harvard Medical School, Division of Genetics, Boston, Massachusetts, USA.
Marc MontminyPeptide Biology Laboratories, The Salk Institute for Biological Studies, La Jolla, California, USA montminy@salk.edu.
Salk Institute for Biological Studies · USHarvard University · USJohns Hopkins University · US

Funding

Viral Vector Core (VVC)P30CA014195 · NCI · SALK INSTITUTE FOR BIOLOGICAL STUDIES · PI Ye Zheng · 1985 to 2026
$82.8M
Regulation of Hepatic Gluconeogenesis by the CREB:TORC2 PathwayR37DK083834 · NIDDK · SALK INSTITUTE FOR BIOLOGICAL STUDIES · PI MONTMINY, MARC R · 2010 to 2018
$6.4M
Protein Acylation and Methylation Mechanisms_Administrative SupplementR37GM062437 · NIGMS · JOHNS HOPKINS UNIVERSITY · PI COLE, PHILIP A · 2013 to 2022
$4.1M
Mechanisms &Inhibition of Histone AcetyltransferasesR01GM062437 · NIGMS · JOHNS HOPKINS UNIVERSITY · PI COLE, PHILIP A · 2001 to 2012
$3.8M
Regulation of Hepatic Gluconeogenesis by the CREB:TORC2 PathwayR01DK083834 · NIDDK · SALK INSTITUTE FOR BIOLOGICAL STUDIES · PI MONTMINY, MARC R · 2009 to 2022
$3.7M
NCI NIH HHS P30 CA014195NIDDK NIH HHS R01 DK083834NIDDK NIH HHS R37 DK083834NIGMS NIH HHS R01 GM062437NIGMS NIH HHS R37 GM062437
6 · The paper itself

Abstract

CREB mediates effects of cyclic AMP on cellular gene expression. Ubiquitous CREB target genes are induced following recruitment of CREB and its coactivators to promoter proximal binding sites. We found that CREB stimulates the expression of pancreatic beta cell-specific genes by targeting CBP/p300 to promoter-distal enhancer regions. Subsequent increases in histone acetylation facilitate recruitment of the coactivators CRTC2 and BRD4, leading to release of RNA polymerase II over the target gene body. Indeed, CREB-induced hyperacetylation of chromatin over superenhancers promoted beta cell-restricted gene expression, which is sensitive to inhibitors of CBP/p300 and BRD4 activity. Neurod1 appears critical in establishing nucleosome-free regions for recruitment of CREB to beta cell-specific enhancers. Deletion of a CREB-Neurod1-bound enhancer within the

Indexed as

AcetylationAnimalsBasic Helix-Loop-Helix ProteinsBromodomain Containing ProteinsCell LineCyclic AMP Response Element-Binding ProteinE1A-Associated p300 ProteinGene Expression RegulationGene Regulatory NetworksInsulin-Secreting CellsMaleMiceNerve Tissue ProteinsNuclear ProteinsOrgan SpecificityPromoter Regions, GeneticBasic Helix-Loop-Helix ProteinsBrd4 protein, mouseBromodomain Containing ProteinsCreb1 protein, mouseCrtc2 protein, mouseCyclic AMP Response Element-Binding ProteinE1A-Associated p300 ProteinEp300 protein, mouseNerve Tissue ProteinsNeurogenic differentiation factor 1Nuclear ProteinsRNA Polymerase IITranscription Factorsbeta cellBRD4cAMPCBPCREBCRTC2insulinNeuroD1PKA

Identifiers

PMID31182641
PMCPMC6692124
OpenAlexW2952401220

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.